Keith B. Marschke
No ORCID on file
· 1 paper in corpus
· active 1999
Development of antiprogestins as a new class of therapeutic agents has been of great interest to the pharmaceutical industry for decades. Currently, all clinically available antiprogestins are compounds with a steroidal skeleton. The new ge…